While different classes of abused drugs interact with distinct signaling substrates, it appears that all utilize receptors in the mesolimbic dopamine system to mediate their reinforcing effects. The regulator of G-protein signaling (RGS) proteins modulate G-protein coupled receptor (GPCR) signaling by increasing the rate of GTP hydrolysis of G proteins. This study was undertaken to determine whether morphine, cocaine, or amphetamine would modulate RGS4 mRNA levels in relevant brain regions. Acute administration of morphine and cocaine decreased levels of RGS4 mRNA in the reticulotegmental pontine nucleus (RtTg) and locus coeruleus (LC). Increases in RGS 4 mRNA levels were observed in the nucleus accumbens (NAc) and dorsal central gray (CGD). Acute drug challenge after chronic drug administration increased RGS4 mRNA in the CGD and decreased RGS4 levels in the red nucleus and RtTg. Interestingly, the LC exhibited biphasic modulation, with decreased RGS4 mRNA levels after acute administration and increased levels after chronic administration. These findings indicate that RGS4 mRNA levels are modulated in a similar manner by different drugs of abuse and imply that a common substrate could mediate some effects of abused drugs. © 2002 Elsevier Science (USA)
The mechanisms by which abused drugs mediate their varied effects are incompletely understood. The longstanding observation that some behavioral effects of abused drugs may tolerate over time, while other may sensitize, remains an apparent paradox. It is not clear whether this is due to similar actions of drugs of abuse upon different neural circuits mediating the divergent effects or to differential modulation of common signaling substrates in different brain regions.
Studies have indicated that G-protein coupled receptors (GPCRs) may play an important role in mediating the effects of abused drugs. Both D1 and D2 receptors in the mesolimbic dopamine system have been shown to play an important role in mediating drug reinforcement (Koob, 1992) . In addition, the -opioid receptor is G-protein coupled (Thompson et al., 1993) . Numerous studies have also demonstrated a potential role for many signaling molecules that are regulated by GPCRs (e.g., cAMP, PKA, CREB) in the actions of abused drugs (Sharma et al., 1975) .
RGS proteins are a class of GTPase activating proteins (GAPs) that increase the rate of GTP hydrolysis of G ␣ and subunits by altering their conformation, thereby desensitizing signaling (Koelle and Horvitz, 1996) . There are over twenty known RGS proteins, with varying tissue distributions and substrate specificities (Druey et al., 1996) . Recent studies have suggested a prominent role for RGS proteins in regulating neural function. Investigators have demonstrated the role of RGS proteins in modulating ion channel function (Diverse-Pierluissi et al., 1999) , and other work has shown regulation of RGS2 mRNA after seizures (Ingi et al., 1998) . Recent evaluation of an RGS2 knockout mouse revealed a phenotype of decreased anxiety and less aggression in males (Oliveira-do-Santos et al., 2000) . It has also been shown that RGS regulation can 
